Clinical Trials · NCT06191848
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- University of Melbourne
- Enrollment
- 352
- Start date
- Nov 2024
- Locations
- 4 sites, Australia
- Primary endpoint
- Percentage of patients who undergo knee replacement in the target joint